Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy. Despite the development of multimodality treatments, including surgical resection, radiotherapy, and chemotherapy, the long-term prognosis of patients with PDAC remains poor. Recently, the introduction of neoadjuvant treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yun, Huang, Zi-Xing, Song, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192284/
https://www.ncbi.nlm.nih.gov/pubmed/34168406
http://dx.doi.org/10.3748/wjg.v27.i22.3037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192284/
https://www.ncbi.nlm.nih.gov/pubmed/34168406
http://dx.doi.org/10.3748/wjg.v27.i22.3037

Ejemplares similares